Skip to main content

Part of OCAFP - Geographic variation

Appendicies 1-9

This contains appendices 1-9 of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England.

Current Chapter

Current chapter – Appendicies 1-9


Summary

This contains appendices 1-9 of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England.


Contents

Please select the download button below to view the following tables of data tables:

Appendix 1 - Tumour characteristics and patient demographics of the full cohort (n=17,155) 

Appendix 2 - Tumour characteristics and patient demographics of the analytical cohort, FIGO Stage 2-4 (n=13,889)

Appendix 3 - Probability of receiving any treatment versus no treatment (n=13,889)

Appendix 4 - Probability of receiving any surgery versus no surgery (n=13,889)

Appendix 5 - Probability of receiving any chemotherapy versus no chemotherapy (n=13,889)

Appendix 6 - Probability of receiving primary surgery with adjuvant chemotherapy versus neoadjuvant chemotherapy with interval debulking surgery (n=6,065)

Appendix 7 - List of major surgical resection codes

Appendix 8 - Comorbid conditions and scoring applied for the derivation of a Charlson comorbidity score

Appendix 9 - Probability of receiving any treatment versus no treatment with and without adjustment for patient performance status (n=5,823)


Data download

Last edited: 12 April 2023 2:08 pm